Power to the Patients podcast

70% Remission for Postpartum Depression? The Psychedelic Breakthrough

0:00
35:54
Manda indietro di 15 secondi
Manda avanti di 15 secondi
Postpartum depression treatment advances with psychedelic therapy. Greg Mayes of Reunion Neuroscience discusses luvesilocin drug development. This episode explores how shorter-acting psilocybin analogs offer new hope for mothers. Greg highlights the success of the RECONNECT study and the path to FDA breakthrough designation.

Altri episodi di "Power to the Patients"